Why did director Crowley not bother to accept and support the...

Why did director Crowley not bother to accept and support the company by accepting his rights issue entitlement back in December.
Does the significant delay or rejection of the spirosonic device and app by theUS Fda mean the future sales of spirosonic devices in US won’t happen and does this significantly affect the relationship and ongoing sales with koneksa health that the company has previously trumped as being significant.
Has the company even thought about pushing extremely hard to boast Australian local sales of all devices being most countries now focus and try help own country made devices like China has done.
Why has Uscom increased tendering on the tender bid centre Chinese medical site significant since June yet China sales have detioriatwd badly. Are they just tendering but losing most or all.
How have Indian sales of spirosonic and other devices gone and have they also declined significantly since initially showing promise years ago.
what happen to the ehealth app that ceo mentioned many times as having huge potential.
why has the bp+ device been a huge disappointment over its entire lifetime in regard to sales .
what happen to the other largest US top 10 hospitals that ceo mention were looking at purchasing 1a devices a longtime ago.
has the newUS distribution partner made significant success in opening new sales.